Latest News

Yatsen Issues 2022 ESG Report

GUANGZHOU, China, July 31, 2023 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leadingChina-based beauty group, today announced that it has published its 2022 Environmental, Social and Governance ("ESG") report, outlining the Company's progress and performance i...

2023-07-31 19:00 2643

Taoping Announces 1-for -10 Reverse Stock Split

SHENZHEN, China, July 31, 2023 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company" or "Taoping"), today announced that the board of directors of the Company approved a one-for-ten reverse stock split of the Company's issued and outstanding ordinary shares, no par value (the "Ordinary Shares...

2023-07-31 19:00 5155

Canadian Solar Releases 2022 Corporate Sustainability Report

GUELPH, ON, July 31, 2023 /PRNewswire/ -- Canadian Solar Inc.  (the "Company", or "Canadian Solar") (NASDAQ: CSIQ) today announces the release of its 2022 Sustainability Report, which highlights the Company's progress toward advancing its sustainability strategy fr...

2023-07-31 19:00 3095

WuXi AppTec Announced Strong Results of the Second Quarter and First Half of 2023, on Top of an Exceptionally Strong Year in 2022

* Revenue of RMB9,908 Million in the Second Quarter, Up 6.7% Year-over-Year; Excluding COVID-19 Commercial Projects, Up 39.5% * Revenue of RMB18,871 Million in the First Half, Up 6.3% Year-over-Year; Excluding COVID-19 Commercial Projects, Up 27.9% * Net Profit Attributable to Owners of the Co...

2023-07-31 18:02 5358

Emeren Group Announces Sale of First RTB Solar Power Project in Germany

STAMFORD, Conn., July 31, 2023 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com ) (NYSE: SOL), a leading global solar project developer, owner, and operator, recently announced the successful sale of an 11.5 MWp PV project to the Swiss-based ener...

2023-07-31 18:00 2752

111 to Announce Second Quarter 2023 Unaudited Financial Results on August 24, 2023 - Conference Call to Follow

SHANGHAI, July 31, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial result...

2023-07-31 17:59 2640

GEHI to Hold Extraordinary General Meeting of Shareholders on September 11, 2023

BEIJING, July 31, 2023 /PRNewswire/ -- Gravitas Education Holdings, Inc. ("GEHI " or the "Company") (NYSE: GEHI), a leading early childhood education service provider inChina, today announced that it will hold an extraordinary general meeting of shareholders (the "EGM") at 3/F, No. 28 Building, Fa...

2023-07-31 17:51 4900

Biosion Announces Phase II Study Start for Anti-TSLP mAb BSI-045B in Atopic Dermatitis (ADAMANT)

NEWARK, N.J. and NANJING, China, July 31, 2023 /PRNewswire/ -- Biosion USA, Inc. (Biosion), a global clinical-stage R&D biotechnology company, today announced the phase 2 study initiation for the evaluation of BSI-045B, an anti-TLSP mAb, in the treatment of atopic dermatitis (AD) . "We are pleas...

2023-07-31 17:05 4689

Cyrusher First Mid-drive E-bike Nitro Comes Out, Redefining Speed Riding

LOGAN, Utah, July 31, 2023 /PRNewswire/ -- Cyrusher, the professional e-bike producer, will launch pre-sales ofthe Nitro, the company's first mid-motor model, in late-July. This is an ebike with great comfort and speed for your 2023 riding adventure....

2023-07-31 16:58 3717

Asia Green Fund Post-investment Management Method: "Nurtured" Service to Help Portfolios with High-Quality Development

BEIJING, July 31, 2023 /PRNewswire/ -- "Empowerment" is the core competence of PE/VC institutions after investment. Asia Green Fund (AGF) has always adhered to the investment strategy of "pursuing both financial returns and environmental benefits", focused on the logic of "technology empowerment"...

2023-07-31 16:02 2485

Global Times: Heritage sites-turned Hanzhong Museum to enrich Han Dynasty's cultural abundance

HANZHONG, China, July 31, 2023 /PRNewswire/ -- Chinese President Xi Jinping visited Hanzhong in northwestChina's Shaanxi Province on his way back to Beijing on Saturday. During his visit to the municipal museum, Xi emphasized making good use of museums. He also called for efforts to expand the in...

2023-07-31 15:51 2180

GLOBAL SARCOMA THERAPY NOW LISTED ON PHARMACEUTICAL BENEFITS SCHEME

* YONDELIS® (trabectedin) now PBS listed for Australian patients * Listing described as "wonderful news" for patients living with rare lipo and leiomyo sarcomas * YONDELISÒ (trabectedin) demonstrates 45% reduction in risk of disease progression or death versus dacarbazine1 SINGAPORE, July 31...

2023-07-31 15:00 2719

LG Energy Solution Crosses Halfway Mark in Its Journey to Reach Carbon Neutrality

* LGES' ESG Report 2022 published today, announcing a string of sustainable business management progress made in the previous year * 61 percent of the electricity used in the company's global production sites was generated from renewable sources… 56 percent when including non-manufacturing bu...

2023-07-31 14:52 2417

Global Times: Chengdu Universiade kicks off with spirit of inclusiveness

BEIJING, July 31, 2023 /PRNewswire/ -- The 31st FISU World University Games, the first major international sports event held in China  in the post-epidemic era, officially kicked off in Southwestern cityChengdu, with the cauldron ignited in the stadium on Friday evening. Analysts said the signifi...

2023-07-31 14:27 2110

U.S. FDA Accepts Biologics License Application for GC Biopharma's GC5107B (Immune Globulin Intravenous (Human), 10% Liquid)

YONGIN, South Korea, July 31, 2023 /PRNewswire/ -- GC Biopharma (006280.KS), a global biopharmaceutical company dedicated to specialty plasma-derived therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company's resubmission of the Biologics License App...

2023-07-31 13:20 2529

J INTS BIO, Novel Oral 4th Generation EGFR TKI 'JIN-A02' - Dosing of First Patient in the Global Multi-center Phase 1/2 Clinical Study began

SEOUL, South Korea, July 31, 2023 /PRNewswire/ -- J INTS BIO announced the successful dosing of the first patient in its global multi-center Phase 1/2 clinical study of 'JIN-A02' on 31st July at Severance Hospital, Seoul, Korea. J INTS...

2023-07-31 13:10 1999

Akeso Inc. Published 2023 Interim Results Positive Profit Alert

HONG KONG, July 31, 2023 /PRNewswire/ -- Akeso Inc. ("Akeso", the "Company"; 9926.HK), a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class and best-in-class innovative medicines globally, today announced that it is expected that the Company will r...

2023-07-31 12:33 4625

NMPA and FDA Approved the First-in-Human Clinical Trial Applications to Evaluate LBL-034, An Anti-GPRC5D/CD3 Bispecific Antibody Developed by Leads Biolabs, in Relapsed/Refractory Multiple Myeloma

NANJING, China, July 31, 2023 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs" or "Company") announced today that the National Medical Products Administration (NMPA) and the U.S. Food and Drug Administration (FDA) have approved its first-in-human Investi...

2023-07-31 12:09 1805

Monport Laser Unveils New GP Series and GI Series Fiber Lasers to redefine the Precision and Performance

SEATTLE, July 30, 2023 /PRNewswire/ -- Monport Laser has been at the forefront of laser engraving innovation, spearheading the development of cutting-edge laser engravers and cutters. Building upon its world-leading expertise in the laser engraving industry, the company is now ready to captivate ...

2023-07-31 11:29 1825

Chengdu FISU Games' First Gold Medal Awarded, Medal Ribbon Showcasing Chengdu's Cultural Essence

CHENGDU, China, July 30, 2023 /PRNewswire/ -- On July 29, in the Men's Nanquan of Wushu tournament,China's athlete Cao Maoyuan won the first gold medal at the 31st FISU World University Games with a score of 9.770. Medal Ribbon of Chengd...

2023-07-31 11:21 2545